Development asset linked to Grifols in public FDA and regional records.
pharma · Severe Alpha-1 Antitrypsin Deficiency (AATD)
Grifols
Instituto Grifols S.A.
Grifols drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
ES HQ
1909 Founded
14,121 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- ES
- Founded
- 1909
- Employees
- 14,121
- Programs
- 2
- Drugs
- 2
- Patents
- 0
Grifols pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Grifols drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Grifols in public FDA and regional records.